antidepressants

The Dark Cloud Over Growing Antidepressant Prescriptions

They call it the Great "Recession," but there's no question that these are depressing times. And doctors are writing scripts for antidepressants at an alarming rate -- especially given that many of these doctors aren't psychiatrists. What are the effects on patients who haven't been properly screened?

Two Reasons for Clinical Data Shares to Soar Again

From October 2010 to February 2011, biotech Clinical Data's stock doubled, mostly thanks to FDA approval of its novel antidepressant. But also pushing the stock up -- and making it likely to perhaps double again -- is speculation that a Big Pharma will buy Clinical Data.

A New Antidepressant Maker Has Lots of Folks Excited

Tiny, little-known biotech Clinical Data has developed a potential blockbuster drug called Vilazodone. If OK'd, it would be the first new depression treatment in 15 years. Its potential is so huge that several Big Pharmas are said to looking to buy the startup.

Legal Briefing: Generic Pharmas on the Hook for Drug Safety

An FDA "bioequivalent" certification doesn't exempt generic drugmakers from responsibility for their medication's safety, a judge has ruled. Teva Pharmaceuticals had been sued for the problems its version of antidepressant Wellbutrin has caused users.

Ban Lifted: Pilots Can Take Antidepressants on Job

The government is lifting a 70-year-old ban on letting pilots fly while on antidepressants, citing improvements in the drugs and an unforeseen side effect of the restriction: Depressed pilots kept flying but just kept their conditions secret.